Treatment for Peyronie's disease using radiofrequency and shock wave therapy
Non-ablative Radiofrequency and Low-intensity Shock Wave Therapy in Fibrotic Plaque in Men With Peyronie's Disease: Case Series
NA · Centro de Atenção ao Assoalho Pélvico · NCT06303661
This study is testing a new treatment that combines radiofrequency and shock wave therapy to see if it can help men with Peyronie's disease feel better and improve their sexual function.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | Male |
| Sponsor | Centro de Atenção ao Assoalho Pélvico (other) |
| Locations | 1 site (Salvador, Estado de Bahia) |
| Trial ID | NCT06303661 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the safety and clinical response of non-ablative radiofrequency treatment combined with low-intensity shock wave therapy in men suffering from Peyronie's disease. Participants will complete five validated questionnaires to assess their erectile function, quality of life, and psychological well-being. Physical assessments will include palpation of the fibrotic plaque, pharmacological induction of erection, and ultrasound measurements of the plaque size. The study aims to determine both the safety of the treatment and any clinical improvements experienced by the participants.
Who should consider this trial
Good fit: Ideal candidates are men experiencing clinical complaints related to Peyronie's disease, regardless of the disease stage.
Not a fit: Patients with pacemakers, cardiac defibrillators, or any other electromagnetic implants will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive option for men with Peyronie's disease, potentially improving their symptoms and quality of life.
How similar studies have performed: While this approach is innovative, similar studies exploring non-invasive treatments for Peyronie's disease have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical complaint related to Peyronie's disease; * At any stage of the disease (acute or chronic). Exclusion Criteria: * Users of a pacemaker, cardiac defibrillator implant or any other electromagnetic implant; * Metallic implants over or under the area to be treated.
Where this trial is running
Salvador, Estado de Bahia
- Centro de Atenção ao Assoalho Pelvico — Salvador, Estado de Bahia, Brazil (RECRUITING)
Study contacts
- Study coordinator: Carlos Mamede, doctorade
- Email: carlosmamede@bahiana.edu.br
- Phone: 55 71 996673967
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Peyronie Disease, Non ablative radiofrequency, Low-intensity Shock Waves Therapy